Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Priveterra Acquisition Corp II (NQ: PMGM )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Priveterra Acquisition Corp II

Priveterra Acquisition Corp. II Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
From Priveterra Acquisition Corp. II
Via Business Wire
What's Going On With Priveterra, AEON Biopharma Shares Today?
Priveterra Acquisition Corp (NASDAQ: PMGM) on Monday announced the closing of its business combination with AEON Biopharma. 
Via Benzinga
Priveterra Acquisition Corp. Announces Completion of Business Combination with AEON Biopharma, Inc.
From Priveterra Acquisition Corp.
Via Business Wire
Why Metropolitan Bank Holding Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) jumped 69% to $22.59 after the company announced it reached a settlement with the SEC. 
Via Benzinga
Dow Rises 50 Points; American Express Earnings Top Views
U.S. stocks traded higher this morning, with the Dow Jones gaining around 50 points on Friday. Following the market opening Friday, the Dow traded up 0.14% to 35,275.55 while the NASDAQ rose 0.52% to... 
Via Benzinga
Priveterra Acquisition Corp. Announces Authorization to List on NYSE Upon Completion of Business Combination with AEON Biopharma, Inc.
From Priveterra Acquisition Corp.
Via Business Wire
Priveterra Acquisition Corp. Announces Intention to Transfer to NYSE Upon Completion of Business Combination with AEON Biopharma, Inc.
From Priveterra Acquisition Corp.
Via Business Wire
Why Lucid Group Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Gainers TRxADE HEALTH, Inc. (NASDAQ: MEDS) shares surged 84.1% to $15.54 in pre-market trading after jumping over 15% on Friday. Superlatus, Inc. signed a binding letter of intent to be acquired by... 
Via Benzinga
AEON Biopharma and Priveterra Acquisition Corp. Announce Filing of S-4 Registration Statement for Proposed Business Combination
From Priveterra Acquisition Corp. and AEON Biopharma, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.